658
Views
11
CrossRef citations to date
0
Altmetric
Research Paper

DNA aptamers detecting generic amyloid epitopes

, , , , &
Pages 400-406 | Published online: 09 Aug 2012

Abstract

Amyloids are fibrillar protein aggregates resulting from non-covalent autocatalytic polymerization of various structurally and functionally unrelated proteins. Previously we have selected DNA aptamers, which bind specifically to the in vitro assembled amyloid fibrils of the yeast prionogenic protein Sup35. Here we show that such DNA aptamers can be used to detect SDS-insoluble amyloid aggregates of the Sup35 protein, and of some other amyloidogenic proteins, including mouse PrP, formed in yeast cells. The obtained data suggest that these aggregates and the Sup35 amyloid fibrils assembled in vitro possess common conformational epitopes recognizable by aptamers. The described DNA aptamers may be used for detection of various amyloid aggregates in yeast and, presumably, other organisms.

Introduction

Amyloids were originally described as insoluble protein aggregates causing a number of human diseases, such as Alzheimer, Parkinson, Huntington and prion diseases. Remarkably, unlike the proteins which form them, all amyloids are structurally similar, being composed of fibers with a specific cross-β structure (reviewed refs. Citation1 and Citation2). Amyloids were also found in lower eukaryotes, in particular, in the yeast Saccharomyces cerevisiae, where they may manifest themselves as non-chromosomal heritable genetic determinants (prions).

The best studied of yeast prions is [PSI+], which reflects the aggregated prion state of the translation termination factor eRF3, also called the Sup35 protein. Aggregation reduces the Sup35 function in translation and causes the nonsense suppressor phenotype.Citation3,Citation4 Aggregation of Sup35 is mediated by its N-terminal (N) domain, which is mainly responsible for the prion properties. The C-terminal (C) domain is required for the translation termination and viability. The middle (M) domain is likely to serve as a spacer between the two other domains and also contains a 20-residues sequence important for Sup35 interaction with the Hsp104 chaperone and prion polymer fragmentation.Citation5 Both M and C domains are inessential for the Sup35 conversion into the prion state.Citation6,Citation7 [PSI+] can appear de novo spontaneously with very low frequency,Citation8 which may be significantly increased by transient overproduction of full-length Sup35 or its N-terminal fragmentsCitation9,Citation10 in the presence of another prion, [PIN+]Citation11,Citation12 related to the prion state of the Rnq1 protein.Citation13 [PSI+] has variants (also called strains) differing in the strength of their nonsense suppressor phenotype. Strong [PSI+] variants show efficient nonsense suppression, while its weak variants are less efficient in nonsense suppression.Citation10 Variation in phenotypic manifestation of [PSI+] is related to heritable differences in the structure of Sup35 prion aggregates.Citation14,Citation15 When Sup35 is constantly overproduced in the presence of [PIN+], it mainly forms aggregates, which, in contrast to prions, cannot propagate due to poor fragmentation by the Hsp104 chaperone.Citation16 In vitro the Sup35 protein or its N-terminal fragments, isolated from Escherichia coli, form amyloid fibrils. These fibrils can transform non-prion [psi-] yeast cells to the prion [PSI+] state,Citation15,Citation17 thus demonstrating a direct relation between such fibrils and the prion form of Sup35 propagated in vivo. Though the same relation to in vitro formed fibrils was shown for the yeast prion Ure2 and Rnq1,Citation18,Citation19 the ability of other amyloidogenic proteins to form amyloid aggregates in yeast was never proved, and the only indication of amyloid nature of such aggregates is their insolubility in the presence of strong ionic detergents, such as SDS or sarcosyl, which dissolve almost all other macromolecular complexes in yeast cells.Citation20,Citation21 Detection of amyloids formed in vivo requires availability of reagents distinguishing them from non-amyloid protein aggregates and complexes, which may represent aptamers.

Aptamers are single-stranded DNA or RNA molecules able to bind to various molecular targets. They may have a wide range of applications in therapeutics, biosensing, diagnostics and research (reviewed ref. Citation22). Aptamers can be obtained from a large library of random oligonucleotides through an in vitro selection procedure called SELEX (Systematic Evolution of Ligands by an EXponential enrichment).Citation23 Earlier we used this procedure to generate a set of DNA aptamers against amyloid fibrils formed in vitro by the Sup35 NM fragment.Citation24 Here we show that such DNA aptamers are able to interact with SDS-resistant polymers of the yeast prionogenic protein Sup35, as well as with that of several other amyloidogenic proteins, thus demonstrating their suitability for amyloid detection.

Results

DNA aptamers interact with SDS-insoluble protein aggregates of [PSI+] [PIN+] cells

Earlier, using the SELEX procedure, we have obtained ten DNA aptamers to in vitro-generated Sup35 fibrils, which could recognize these fibrils in an ELISA-like assay.Citation24 Here, we studied the ability of these and 11 additional aptamers, obtained through a similar procedure, to interact with ex vivo detergent-insoluble aggregates of Sup35 and of some other proteins in the dot-blot and western blot procedures. The aptamers () were chemically synthesized and 5′-biotinylated to allow an aptamer-target binding assay. These aptamers lacked ten terminal nucleotides of constant regions at both sides, which did not impair the interaction of aptamers with Sup35 fibrils. More extensive truncation was not tried, since complete removal of 25 nucleotides from flanking regions in aptamer S5 hindered its binding to Sup35NM fibrils.Citation24

Table 1. Nucleotide sequences of variable regions of selected DNA aptamers

All selected aptamers were tested in a dot-blot assay for their ability to bind to SDS-insoluble aggregates purified from lysates of yeast cells containing [PSI+] variant with strong suppressor phenotype ([PSI+]s) and [PIN+]. Most of the aptamers were able to bind to these aggregates, albeit with different efficiency (). Three DNA aptamers were removed from further study, since two of them (A31 and A37) stained the aggregates faintly and one (A24) weakly stained the [psi-] [pin-] control.

Figure 1. DNA aptamers detect prion aggregates of Sup35 partially purified from cells of 5V-H19 [PSI+]s [PIN+]. The [psi-] [pin-] derivative of this strain was used as a control. Aptamer IDs are presented on the left. Samples of protein aggregate fraction were serially diluted in 2-fold increments, as indicated on the top.

Figure 1. DNA aptamers detect prion aggregates of Sup35 partially purified from cells of 5V-H19 [PSI+]s [PIN+]. The [psi-] [pin-] derivative of this strain was used as a control. Aptamer IDs are presented on the left. Samples of protein aggregate fraction were serially diluted in 2-fold increments, as indicated on the top.

DNA aptamers interact with detergent-insoluble aggregates of different amyloidogenic proteins

To further characterize the aptamers, we tested their binding to various detergent-insoluble aggregates. These were isolated from [PIN+] cells either lacking [PSI+] or containing its weak ([PSI+]w) and strong variants. Besides prions, we also studied interaction of aptamers with non-heritable aggregates of overproduced Sup35 or detergent-insoluble aggregates of mouse PrP90–231 and of the model 103Q-GFP protein composed of expanded polyglutamine (polyQ) domain of human huntingtin fused with the green fluorescent protein (GFP). The PrP and huntingtin proteins are related to transmissible encephalopathies (reviewed refs. Citation25 and Citation26) and Huntington disease (reviewed refs. Citation27 and Citation28), respectively.

Many of the studied aptamers were able to recognize not only Sup35 aggregates, but also detergent-insoluble aggregates of the other proteins. This allowed us to assign the aptamers to five classes by the specificity of interaction ( and ). Four aptamers recognized Rnq1 aggregates (classes III and V). These aggregates were isolated from cells of the 74-D694 [psi-] [PIN+] strain. Aggregates from the cells containing prion or non-prion polymers of Sup35 were stained by nearly all of the aptamers. Although these cells also contained [PIN+], the aptamers of the I, II and IV classes could not interact with the Rnq1 prion polymers and thus detected only Sup35 aggregates (). The aptamer S5 (class V) was able to interact with all tested targets. Nevertheless, in [PSI+] [PIN+] cells it primarily detected Sup35 aggregates, as evident from SDD-AGE polymer analysis (). We observed earlier that differential deletion of oligopeptide repeats in the Sup35 prion-forming N-terminal domain results in formation of Sup35 prion polymers of different size.Citation29 Staining of such Sup35 polymers with anti-Sup35 antibody and aptamer S5 revealed a very similar variation of the polymer size. Thus, Sup35 aggregates were the major target of S5. In part, this can be related to Sup35 being much more abundant than Rnq1.

Table 2. DNA aptamers interact differently with various prion and non-prion detergent-insoluble aggregates

Figure 2. Cross-reactivity of DNA aptamers with partially purified detergent-insoluble aggregates of different proteins. (A) Dot-blot assay. Aptamer representatives of each class are presented. Samples of the protein aggregate fraction were serially diluted in 4-fold increments. (B) SDD-AGE analysis. Only targets stained differently by the aptamer classes are presented. Protein aggregates were partially purified from cells of the following strains: PrP, 74-D694ΔRNQ1 [psi-] expressing PrP90–231; 103Q, 74-D694ΔS35 [pin-] expressing 103Q-GFP and Sup35C; [PIN+], 74-D694 [psi-] [PIN+]; NPA Sup35, non-prion aggregates of Sup35 from 74-D694 [psi-] [PIN+] overproducing Sup35; [PSI+]s and [PSI+]w, 5V-H19 [PIN+] carrying either [PSI+]s or [PSI+]w respectively. Controls: [psi-], aggregates from 5V-H19 [psi-] [pin-] cells and mono, monomers obtained from respective aggregates upon their boiling. The staining of mono 103Q by aptamers A18 and S5 probably relates to incomplete dissolution of 103Q upon boiling.

Figure 2. Cross-reactivity of DNA aptamers with partially purified detergent-insoluble aggregates of different proteins. (A) Dot-blot assay. Aptamer representatives of each class are presented. Samples of the protein aggregate fraction were serially diluted in 4-fold increments. (B) SDD-AGE analysis. Only targets stained differently by the aptamer classes are presented. Protein aggregates were partially purified from cells of the following strains: PrP, 74-D694ΔRNQ1 [psi-] expressing PrP90–231; 103Q, 74-D694ΔS35 [pin-] expressing 103Q-GFP and Sup35C; [PIN+], 74-D694 [psi-] [PIN+]; NPA Sup35, non-prion aggregates of Sup35 from 74-D694 [psi-] [PIN+] overproducing Sup35; [PSI+]s and [PSI+]w, 5V-H19 [PIN+] carrying either [PSI+]s or [PSI+]w respectively. Controls: [psi-], aggregates from 5V-H19 [psi-] [pin-] cells and mono, monomers obtained from respective aggregates upon their boiling. The staining of mono 103Q by aptamers A18 and S5 probably relates to incomplete dissolution of 103Q upon boiling.

Figure 3. Interaction of the S5 aptamer with SDS-insoluble aggregates of truncated Sup35. Sup35 aggregates were purified from cells of the strain 22V-H63ΔS35 [PSI+] [PIN+], transformed with one of the plasmids of the pUKC1512 series, which carried wild-type SUP35, or R1-2, R1-3 and R1-4 deletion alleles, encoding Sup35 with indicated number of oligopeptide repeats in the prion-forming N-terminal domain. Staining with the anti-Sup35 antibody and the S5 aptamer.

Figure 3. Interaction of the S5 aptamer with SDS-insoluble aggregates of truncated Sup35. Sup35 aggregates were purified from cells of the strain 22V-H63ΔS35 [PSI+] [PIN+], transformed with one of the plasmids of the pUKC1512 series, which carried wild-type SUP35, or R1-2, R1-3 and R1-4 deletion alleles, encoding Sup35 with indicated number of oligopeptide repeats in the prion-forming N-terminal domain. Staining with the anti-Sup35 antibody and the S5 aptamer.

Five aptamers stained 103Q-GFP aggregates isolated from cells of the 74-D694ΔS35 [pin-] strain, which overproduced 103Q-GFP and contained only the non-polymerizing Sup35C protein. The assignment of aptamers specificity in this case was complicated by the observations that 103Q-GFP polymers can seed polymerization of various chromosomally-encoded glutamine/asparagine-rich proteinsCitation30,Citation31 and these polymers could also be detected by aptamers. However, it is unlikely that these polymers contribute significantly to staining, since they should be much less abundant than aggregates of overproduced 103Q-GFP. Otherwise, aptamers would stain all isolated aggregates. However, quite the contrary, among 18 aptamers only five, belonging to the classes II and V, interacted with aggregates isolated from cells expressing 103Q-GFP ().

All tested aptamers stained aggregates isolated from cell lysates of the strain 74-D694ΔRNQ1 [psi-] expressing PrP90–231. The staining was not due to induced aggregation of Sup35, since no detergent-insoluble Sup35 polymers were detected with anti-Sup35 antibodies (). It is surprising that all aptamers stained aggregates of PrP90–231, which shares no similarity with Sup35, while only few aptamers stained aggregates of Q103-GFP or Rnq1, which, similarly to Sup35, have glutamine-rich polymerization domains. It is known that PrP is capable of nonspecific interaction with nucleic acidsCitation32 via its N-terminal region,Citation33 probably due to the presence of two lysine clusters, one of which is present in PrP90–231. We observed that this interaction was insufficiently strong to ensure staining of PrP90–231, since the aptamers did not stain soluble heat-denatured PrP90–231 (), while the shortened aptamer S5 lacking 15 nucleotide constant flanks and the 70-nucleotide long DNA aptamer against human pro-urokinaseCitation34 did not bind either PrP90–231 nor Sup35 aggregates (). However, the weak nonspecific affinity of polynucleotides toward PrP could strengthen the specific interaction of aptamers with PrP90–231 aggregates, resulting in universal binding of all aptamers to these aggregates.

Figure 4. Staining of detergent-insoluble PrP90–231 aggregates of 74-D694ΔRNQ1 [psi-] by aptamers is not due to non-specific DNA binding. [PSI+] [PIN+], 5V-H19 [PSI+]s [PIN+]; [psi-] [pin-], 5V-H19 [psi-] [pin-]; PrP, 74-D694ΔRNQ1 [psi-] expressing PrP90–231. Sup35 Ab and PrP Ab, antibodies against Sup35 and PrP, respectively; S5, S5-40 and U-1, DNA aptamers S5, S5 without 15 nucleotides from each flank and aptamer against human pro-urokinase, respectively.

Figure 4. Staining of detergent-insoluble PrP90–231 aggregates of 74-D694ΔRNQ1 [psi-] by aptamers is not due to non-specific DNA binding. [PSI+] [PIN+], 5V-H19 [PSI+]s [PIN+]; [psi-] [pin-], 5V-H19 [psi-] [pin-]; PrP, 74-D694ΔRNQ1 [psi-] expressing PrP90–231. Sup35 Ab and PrP Ab, antibodies against Sup35 and PrP, respectively; S5, S5-40 and U-1, DNA aptamers S5, S5 without 15 nucleotides from each flank and aptamer against human pro-urokinase, respectively.

Dot-blot assay could not be used for detection of protein aggregates by biotin-labeled aptamers in cell lysates, since lysates contain biotinylated proteins, which are stained by streptavin-peroxidase (data not shown). However, separation of SDS-insoluble aggregates from soluble proteins by SDD-AGE makes purification of such aggregates unnecessary for the study of their interaction with aptamers. Thus, SDD-AGE is a suitable approach for the aptamer-assisted detection of SDS-insoluble polymers of various proteins ().

Figure 5. S5 aptamer interacts with SDS-insoluble aggregates in crude cell lysates. [PIN+], 74-D694 [psi-] [PIN+]; 103Q, 70Q and 76QY, 74-D694 [psi-] [pin-], expressing 103Q-GFP,Citation37 70Q-Sup35MC and 76QY-Sup35MC,Citation38 respectively; [PSI+], 5V-H19 [PSI+]s [PIN+]; [psi-], 5V-H19 [psi-] [pin-]. Staining with S5 aptamer or with antibodies against Rnq1, GFP or Sup35.

Figure 5. S5 aptamer interacts with SDS-insoluble aggregates in crude cell lysates. [PIN+], 74-D694 [psi-] [PIN+]; 103Q, 70Q and 76QY, 74-D694 [psi-] [pin-], expressing 103Q-GFP,Citation37 70Q-Sup35MC and 76QY-Sup35MC,Citation38 respectively; [PSI+], 5V-H19 [PSI+]s [PIN+]; [psi-], 5V-H19 [psi-] [pin-]. Staining with S5 aptamer or with antibodies against Rnq1, GFP or Sup35.

Discussion

In this work we observed that DNA aptamers obtained against amyloid fibrils of the yeast prionogenic protein Sup35 can bind to detergent-insoluble aggregates formed in yeast cells by various structurally and functionally unrelated proteins. This suggests that cellular detergent-insoluble aggregates and the Sup35 fibrils assembled in vitro possess common structures recognizable by aptamers and, therefore, the interaction with aptamers indicates the amyloid nature of such aggregates.

Earlier, an RNA aptamer to β2-microglobulin amyloid was generated, which was able to interact with amyloids of lysozyme, though not with three other tested amyloids.Citation35 Similar, but wider, cross-reactivity was shown by DNA aptamers studied here: aptamers against Sup35 amyloid fibrils could interact with prion and non-prion detergent-insoluble aggregates of different proteins isolated from yeast cells. The observed interactions depended on both the aptamer and the target aggregate used in the binding assay. It should be noted that since the amounts of aggregates of different proteins in samples were difficult to equalize correctly, the quantitative comparison of the ability of aptamers to stain different targets was not possible. On the other hand, different aptamers could be compared with each other by the efficiency of interaction with the same target.

Basing on the specificity of interaction, all tested DNA aptamers were assigned to five classes (). Most of the aptamers detected prion and non-prion aggregates of Sup35. Nevertheless, binding of some aptamers depended on the variations of Sup35 amyloid folding. Three aptamers (S6, A2 and A21; class I) differed from others being especially efficient against [PSI+]s, whereas one aptamer (A26; class IV) did not interact with [PSI+]w and the non-prion aggregates of Sup35, which should be related to differences in amyloid structure. Aptamers of the classes III and V were able to recognize Rnq1 prion aggregates and class II and V aptamers detected aggregates of 103Q-GFP. Therefore, in vitro formed Sup35 fibrils possess structural determinants, which are shared not only by prion and non-prion aggregates of this protein, but also by detergent-insoluble aggregates of other proteins.

Sup35, Rnq1 and polyQ proteins all have glutamine-rich polymerization domains, while PrP does not share this feature. Nevertheless, PrP90–231 aggregates were readily recognized by all tested aptamers. The only structural trait common for amyloid conformations of PrP and other studied proteins is the presence of intermolecular β-sheets typical of all amyloids. The presence of common epitopes in amyloid aggregates of polyQ and of proteins, which are not rich in glutamine and asparagine residues, such as Alzheimer Aβ(1–40) peptide, lysozyme and some other proteins, was also observed with the use of specific conformational antibodies.Citation36

The results of this work show that DNA aptamers can be used for the detection of various amyloid aggregates. The higher stability of DNA aptamers gives them an advantage over RNA aptamers and allows using them in complex media containing RNases, for example, for detection of amyloid aggregates of cell lysates, as was shown in this work. This makes described DNA aptamers convenient reagents which can be used for the detection and characterization of amyloid aggregates in yeast and other organisms.

Materials and Methods

Plasmids, strains and growth conditions

The strains and plasmids used in this study are described in and , respectively. Yeast were grown at 30°C in rich (YPD, 1% yeast extract, 2% peptone, 2% glucose) or synthetic (SC, 0.67% yeast nitrogen base, 2% glucose supplemented with the required amino acids) media. To induce the synthesis of the 103Q-GFP chimeric protein, transformants with the p103Q-GFP plasmid were incubated in liquid selective media with 2% raffinose as a sole carbon source to mid-log phase. Then, the culture was diluted with an equal volume of the same medium with galactose instead of raffinose and cells were grown for 6 h. The final concentration of galactose in the medium was 2%.

Table 3. Strains

Table 4. Plasmids

Preparation of yeast cell lysates

Yeast cultures grown in liquid selective media were harvested, washed in water and lyzed by glass beads in buffer A: 30 mM TRIS-HCl, pH 7.4, 150 mM NaCl, 10 mM EDTA, 1 mM dithiothreitol and 1% Triton X-100. To prevent proteolytic degradation, Complete protease inhibitor cocktail (Roche Applied Science) and phenylmethylsulfonyl fluoride (final concentration 10 mM) were added. Cell debris was removed by centrifugation at 1,500 g for 4 min.

Centrifugation

Detergent insoluble protein aggregates were isolated as described.Citation21 Two to four milliliters of yeast cell lysate were centrifuged at 200,000 g for 1 h at 4°C. Pellet was dissolved in TBS with 3% Sarkosyl and Complete protease inhibitor cocktail (Roche Applied Science), placed in a tube over 20% sucrose solution with 0.3% of Sarkosyl (1/3 of the sample volume) and centrifuged at 200,000 g for 14 h at 6°C. The obtained pellet was dissolved again in TBS with 2% SDS or 3% Sarkosyl in the case of PrP, placed in a tube over 20% sucrose solution with 0.2% SDS or 0.3% Sarkosyl in the case of PrP (1/3 of the sample volume) and centrifuged for 14 h at 240,000 g, 15°C. Control protein aggregate fractions from crude cell lysates of [psi-] [pin-] cells were obtained in the same way.

Electrophoresis and blotting

Separation of proteins by semidenaturing electrophoresis in agarose gel (SDD-AGE) was performed as described previously.Citation20,Citation21 Protein loads were equalized for each gel. For analysis of amyloid polymers we used horizontal 1.8% agarose gels in the Tris-Acetate-EDTA (TAE) buffer with 0.1% SDS. Lysates were incubated in the sample buffer (0.5x TAE, 2% SDS, 5% glycerol and 0.05% Bromophenol Blue) for 5 min at 37°C. After the electrophoresis, proteins were transferred from gels to nitrocellulose membrane sheets (ThermoScientific) by vacuum-assisted capillary blotting for 5 h (agarose gels). Bound antibody was detected using the ECL West Dura system (Thermo Scientific). Rabbit polyclonal antibodies against Sup35 and Rnq1 were used. Anti-GFP mouse monoclonal antibody 3A9 was obtained from Rusbiolink. Anti-PrP rabbit monoclonal antibody EP1802Y was obtained from Abcam.

Aptamer binding assays

Proteins of the total cell lysates or their aggregate fractions were separated by SDD-AGE, transferred to nitrocellulose membrane as described above, and the membrane was incubated for 1 h with blocking buffer (TBS with 0,4% casein and 0.05% tween 20). The aliquot of 5′-biotinilated aptamer was diluted to final 12 pmoles/ml concentration with PSU buffer (500 µl of 5 mM sodium phosphate, pH 6.0, 150 mM NaCl, 0,2 mM urea), boiled for 5 min, incubated at 25Co for 1 h and diluted 10-fold with mixture of equal volumes of PSU and blocking buffers. The streptavidin peroxidase conjugate was then added at desired concentration; solution was rotated for 20 min at room temperature and then poured out to nitrocellulose membrane. Dot blot assays were used only to detect binding of aptamers with proteins in aggregate fractions isolated from yeast cell lysates. Equal amount of total protein (confirmed by staining the same membranes by Ponceau S, a non-specific protein stain) from each preparation was serially diluted as indicated and applied to nitrocellulose membrane using 96-well sample vacuum microfiltration blotting device (Bio-Rad). Then, the membrane was processed as described above. Bound streptavidin-peroxidase conjugate was detected using the ECL West Dura system (Thermo Scientific).

Abbreviations:
SELEX=

systematic evolution of ligands by an exponential enrichment

polyQ=

polyglutamine

GFP=

the green fluorescent protein

Acknowledgments

The work was supported by the Ministry of Education and Science of the Russian Federation (no. 11.519.11.2001) and the grant from Russian Foundation for Basic Research no. 11-04-00442. Some parts of the study were performed in the Applied Biotechnologies Center for Collective Use, Bach Institute of Biochemistry, Russian Academy of Sciences. Authors are grateful to Alexey Galkin for providing the plasmid pL-moPrP(90-231), Michael Sherman for the plasmid p103Q-GFP, and Mick Tuite for the plasmids of the pUKC1512-SUP35 series.

Disclosure of Potential Conflicts of Interest

No potential conflicts of interest were disclosed.

References

  • Chiti F, Dobson CM. Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 2006; 75:333 - 66; http://dx.doi.org/10.1146/annurev.biochem.75.101304.123901; PMID: 16756495
  • Kajava AV, Squire JM, Parry DAD. β-structures in fibrous proteins. Adv Protein Chem 2006; 73:1 - 15; http://dx.doi.org/10.1016/S0065-3233(06)73001-7; PMID: 17190609
  • Paushkin SV, Kushnirov VV, Smirnov VN, Ter-Avanesyan MD. Propagation of the yeast prion-like [psi+] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. EMBO J 1996; 15:3127 - 34; PMID: 8670813
  • Patino MM, Liu JJ, Glover JR, Lindquist S. Support for the prion hypothesis for inheritance of a phenotypic trait in yeast. Science 1996; 273:622 - 6; http://dx.doi.org/10.1126/science.273.5275.622; PMID: 8662547
  • Helsen CW, Glover JR. Insight into molecular basis of curing of [PSI+] prion by overexpression of 104-kDa heat shock protein (Hsp104). J Biol Chem 2012; 287:542 - 56; http://dx.doi.org/10.1074/jbc.M111.302869; PMID: 22081611
  • Ter-Avanesyan MD, Kushnirov VV, Dagkesamanskaya AR, Didichenko SA, Chernoff YO, Inge-Vechtomov SG, et al. Deletion analysis of the SUP35 gene of the yeast Saccharomyces cerevisiae reveals two non-overlapping functional regions in the encoded protein. Mol Microbiol 1993; 7:683 - 92; http://dx.doi.org/10.1111/j.1365-2958.1993.tb01159.x; PMID: 8469113
  • Ter-Avanesyan MD, Dagkesamanskaya AR, Kushnirov VV, Smirnov VN. The SUP35 omnipotent suppressor gene is involved in the maintenance of the non-Mendelian determinant [psi+] in the yeast Saccharomyces cerevisiae.. Genetics 1994; 137:671 - 6; PMID: 8088512
  • Cox BS, Tuite MF, McLaughlin CS. The psi factor of yeast: a problem in inheritance. Yeast 1988; 4:159 - 78; http://dx.doi.org/10.1002/yea.320040302; PMID: 3059716
  • Chernoff YO, Derkach IL, Inge-Vechtomov SG. Multicopy SUP35 gene induces de-novo appearance of psi-like factors in the yeast Saccharomyces cerevisiae.. Curr Genet 1993; 24:268 - 70; http://dx.doi.org/10.1007/BF00351802; PMID: 8221937
  • Derkatch IL, Chernoff YO, Kushnirov VV, Inge-Vechtomov SG, Liebman SW. Genesis and variability of [PSI] prion factors in Saccharomyces cerevisiae. Genetics 1996; 144:1375 - 86; PMID: 8978027
  • Derkatch IL, Bradley ME, Masse SVL, Zadorsky SP, Polozkov GV, Inge-Vechtomov SG, et al. Dependence and independence of [PSI(+)] and [PIN(+)]: a two-prion system in yeast?. EMBO J 2000; 19:1942 - 52; http://dx.doi.org/10.1093/emboj/19.9.1942; PMID: 10790361
  • Kochneva-Pervukhova NV, Chechenova MB, Valouev IA, Kushnirov VV, Smirnov VN, Ter-Avanesyan MD. [Psi(+)] prion generation in yeast: characterization of the ‘strain’ difference. Yeast 2001; 18:489 - 97; http://dx.doi.org/10.1002/yea.700; PMID: 11284005
  • Derkatch IL, Bradley ME, Hong JY, Liebman SW. Prions affect the appearance of other prions: the story of [PIN(+)]. [PIN+] Cell 2001; 106:171 - 82; http://dx.doi.org/10.1016/S0092-8674(01)00427-5; PMID: 11511345
  • Krishnan R, Lindquist SL. Structural insights into a yeast prion illuminate nucleation and strain diversity. Nature 2005; 435:765 - 72; http://dx.doi.org/10.1038/nature03679; PMID: 15944694
  • Tanaka M, Chien P, Naber N, Cooke R, Weissman JS. Conformational variations in an infectious protein determine prion strain differences. Nature 2004; 428:323 - 8; http://dx.doi.org/10.1038/nature02392; PMID: 15029196
  • Salnikova AB, Kryndushkin DS, Smirnov VN, Kushnirov VV, Ter-Avanesyan MD. Nonsense suppression in yeast cells overproducing Sup35 (eRF3) is caused by its non-heritable amyloids. J Biol Chem 2005; 280:8808 - 12; http://dx.doi.org/10.1074/jbc.M410150200; PMID: 15618222
  • King CY, Diaz-Avalos R. Protein-only transmission of three yeast prion strains. Nature 2004; 428:319 - 23; http://dx.doi.org/10.1038/nature02391; PMID: 15029195
  • Brachmann A, Baxa U, Wickner RB. Prion generation in vitro: amyloid of Ure2p is infectious. EMBO J 2005; 24:3082 - 92; http://dx.doi.org/10.1038/sj.emboj.7600772; PMID: 16096644
  • Patel BK, Liebman SW. “Prion-proof” for [PIN+]: infection with in vitro-made amyloid aggregates of Rnq1p-(132-405) induces [PIN+]. [PIN+] J Mol Biol 2007; 365:773 - 82; http://dx.doi.org/10.1016/j.jmb.2006.10.069; PMID: 17097676
  • Kryndushkin DS, Alexandrov IM, Ter-Avanesyan MD, Kushnirov VV. Yeast [PSI+] prion aggregates are formed by small Sup35 polymers fragmented by Hsp104. J Biol Chem 2003; 278:49636 - 43; http://dx.doi.org/10.1074/jbc.M307996200; PMID: 14507919
  • Kushnirov VV, Alexandrov IM, Mitkevich OV, Shkundina IS, Ter-Avanesyan MD. Purification and analysis of prion and amyloid aggregates. Methods 2006; 39:50 - 5; http://dx.doi.org/10.1016/j.ymeth.2006.04.007; PMID: 16774835
  • Syed MA, Pervaiz S. Advances in aptamers. Oligonucleotides 2010; 20:215 - 24; http://dx.doi.org/10.1089/oli.2010.0234; PMID: 20677985
  • Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990; 249:505 - 10; http://dx.doi.org/10.1126/science.2200121; PMID: 2200121
  • Surina ER, Morozkina EV, Marchenko EV, Ter-Avanesian MD, Benevolenskiĭ SV, Kushnirov VV, et al. [Selection of DNA aptamers, specifically interacting with fibrillar form of the yeast Sup35 protein]. Mol Biol (Mosk) 2009; 43:682 - 8; http://dx.doi.org/10.1134/S0026893309040153; PMID: 19807032
  • Prusiner SB, Scott MR, DeArmond SJ, Cohen FE. Prion protein biology. Cell 1998; 93:337 - 48; http://dx.doi.org/10.1016/S0092-8674(00)81163-0; PMID: 9590169
  • Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 2001; 24:519 - 50; http://dx.doi.org/10.1146/annurev.neuro.24.1.519; PMID: 11283320
  • Sherman MY, Goldberg AL. Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. Neuron 2001; 29:15 - 32; http://dx.doi.org/10.1016/S0896-6273(01)00177-5; PMID: 11182078
  • Takahashi T, Katada S, Onodera O. Polyglutamine diseases: where does toxicity come from? what is toxicity? where are we going?. J Mol Cell Biol 2010; 2:180 - 91; http://dx.doi.org/10.1093/jmcb/mjq005; PMID: 20410236
  • Shkundina IS, Kushnirov VV, Tuite MF, Ter-Avanesyan MD. The role of the N-terminal oligopeptide repeats of the yeast Sup35 prion protein in propagation and transmission of prion variants. Genetics 2006; 172:827 - 35; http://dx.doi.org/10.1534/genetics.105.048660; PMID: 16272413
  • Urakov VN, Vishnevskaya AB, Alexandrov IM, Kushnirov VV, Smirnov VN, Ter-Avanesyan MD. Interdependence of amyloid formation in yeast: implications for polyglutamine disorders and biological functions. Prion 2010; 4:45 - 52; http://dx.doi.org/10.4161/pri.4.1.11074; PMID: 20118659
  • Kochneva-Pervukhova NV, Alexandrov AI, Ter-Avanesyan MD. Amyloid-mediated sequestration of essential proteins contributes to mutant huntingtin toxicity in yeast. PLoS One 2012; 7:e29832; http://dx.doi.org/10.1371/journal.pone.0029832; PMID: 22253794
  • Zeiler B, Adler V, Kryukov V, Grossman A. Concentration and removal of prion proteins from biological solutions. Biotechnol Appl Biochem 2003; 37:173 - 82; http://dx.doi.org/10.1042/BA20020087; PMID: 12630906
  • Mercey R, Lantier I, Maurel MC, Grosclaude J, Lantier F, Marc D. Fast, reversible interaction of prion protein with RNA aptamers containing specific sequence patterns. Arch Virol 2006; 151:2197 - 214; http://dx.doi.org/10.1007/s00705-006-0790-3; PMID: 16799875
  • Skrypina NA, Savochkina LP, Beabealashvilli RSh. In vitro selection of single-stranded DNA aptamers that bind human pro-urokinase. Nucleosides Nucleotides Nucleic Acids 2004; 23:891 - 3; http://dx.doi.org/10.1081/NCN-200026037; PMID: 15560078
  • Bunka DHJ, Mantle BJ, Morten IJ, Tennent GA, Radford SE, Stockley PG. Production and characterization of RNA aptamers specific for amyloid fibril epitopes. J Biol Chem 2007; 282:34500 - 9; http://dx.doi.org/10.1074/jbc.M703679200; PMID: 17878167
  • O’Nuallain B, Wetzel R. Conformational Abs recognizing a generic amyloid fibril epitope. Proc Natl Acad Sci U S A 2002; 99:1485 - 90; http://dx.doi.org/10.1073/pnas.022662599; PMID: 11818542
  • Meriin AB, Zhang X, He X, Newnam GP, Chernoff YO, Sherman MY. Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1. J Cell Biol 2002; 157:997 - 1004; http://dx.doi.org/10.1083/jcb.200112104; PMID: 12058016
  • Alexandrov IM, Vishnevskaya AB, Ter-Avanesyan MD, Kushnirov VV. Appearance and propagation of polyglutamine-based amyloids in yeast: tyrosine residues enable polymer fragmentation. J Biol Chem 2008; 283:15185 - 92; http://dx.doi.org/10.1074/jbc.M802071200; PMID: 18381282
  • Wang P, Hatcher KL, Bartz JC, Chen SG, Skinner P, Picht J, et al. Selection and characterization of DNA aptamers against PrPSc. Exp Biol Med 2011; 236:466 - 76; http://dx.doi.org/10.1258/ebm.2011.010323
  • Chernoff YO, Lindquist SL, Ono B, Inge-Vechtomov SG, Liebman SW. Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]. [psi+] Science 1995; 268:880 - 4; http://dx.doi.org/10.1126/science.7754373; PMID: 7754373
  • Parham SN, Resende CG, Tuite MF. Oligopeptide repeats in the yeast protein Sup35p stabilize intermolecular prion interactions. EMBO J 2001; 20:2111 - 9; http://dx.doi.org/10.1093/emboj/20.9.2111; PMID: 11331577
  • Urakov VN, Valouev IA, Kochneva-Pervukhova NV, Packeiser AN, Vishnevsky AY, Glebov OO, et al. N-terminal region of Saccharomyces cerevisiae eRF3 is essential for the functioning of the eRF1/eRF3 complex beyond translation termination. BMC Mol Biol 2006; 7:34; http://dx.doi.org/10.1186/1471-2199-7-34; PMID: 17034622

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.